0
Back To Top Jump Location
Sign In  | Cart
Journals | Topic Collections | CME | Guidelines | Subscribe
Left Shadow
Right Shadow
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

Clinical Research |  April 01, 2013
The REMEDEE Trial: A Randomized Comparison of a Combination Sirolimus-Eluting Endothelial Progenitor Cell Capture Stent With a Paclitaxel-Eluting Stent
Michael Haude, MD, PhD; Stephen W.L. Lee, MD; Stephen G. Worthley, MBBS, PhD; et al.
J Am Coll Cardiol Intv. 2013;6(4):334-343. doi:10.1016/j.jcin.2012.10.018.
INCLUDES: Supplemental Content
Clinical Research |  April 01, 2013
The “Final” 5-Year Follow-Up From the ENDEAVOR IV Trial Comparing a Zotarolimus-Eluting Stent With a Paclitaxel-Eluting Stent
Ajay J. Kirtane, MD, SM; Martin B. Leon, MD; Michael W. Ball, MD; et al.
J Am Coll Cardiol Intv. 2013;6(4):325-333. doi:10.1016/j.jcin.2012.12.123.
Images in Intervention |  April 01, 2013
Coronary Artery Aneurysms After Sirolimus-Eluting Stent Implantation: Multimodality Imaging Evaluation
Yusuke Fujino, MD; Guilherme F. Attizzani, MD; Sunao Nakamura, MD, PhD; et al.
J Am Coll Cardiol Intv. 2013;6(4):423-424. doi:10.1016/j.jcin.2012.08.023.
Clinical Studies |  March 21, 2013 ONLINE FIRST
Zotarolimus-Eluting and Paclitaxel-Eluting Stents in an All-Comer Population in China: RESOLUTE China Randomized Controlled Trial
Bo Xu, MBBS; Yuejin Yang, MD; Zuyi Yuan, MD; et al.
J Am Coll Cardiol Intv. 2013;():. doi:10.1016/j.jcin.2013.03.001.
INCLUDES: Supplemental Content
Clinical Research |  March 01, 2013
2-Year Results of Paclitaxel-Eluting Balloons for Femoropopliteal Artery Disease: Evidence From a Multicenter Registry
Antonio Micari, MD, PhD; Angelo Cioppa, MD; Giuseppe Vadalà, MD; et al.
J Am Coll Cardiol Intv. 2013;6(3):282-289. doi:10.1016/j.jcin.2013.01.128.
Clinical Research |  March 01, 2013
Percutaneous Revascularization for Peripheral Arterial Disease: Paclitaxel Saves the Day⁎⁎ 
Ehtisham Mahmud, MD
J Am Coll Cardiol Intv. 2013;6(3):290-292. doi:10.1016/j.jcin.2013.02.003.
Images in Intervention |  March 01, 2013
Acute Stent Recoil From Aggressive Post-Dilation of a Second-Generation Drug-Eluting Stent
Kensuke Takagi, MD; Tadayuki Yakushiij, MD; Sandeep Basavarajaiah, MD; et al.
J Am Coll Cardiol Intv. 2013;6(3):311-313. doi:10.1016/j.jcin.2012.08.027.
Clinical Research |  March 01, 2013
Incidence and Short-Term Clinical Outcomes of Small Side Branch Occlusion After Implantation of an Everolimus-Eluting Bioresorbable Vascular Scaffold: An Interim Report of 435 Patients in the ABSORB-EXTEND Single-Arm Trial in Comparison With an Everolimus-Eluting Metallic Stent in the SPIRIT First and II Trials
Takashi Muramatsu, MD, PhD; Yoshinobu Onuma, MD; Hector M. García-García, MD, PhD; et al.
J Am Coll Cardiol Intv. 2013;6(3):247-257. doi:10.1016/j.jcin.2012.10.013.
INCLUDES: Supplemental Content
Clinical Research |  March 01, 2013
Moderate Procedural Sedation and Opioid Analgesia During Transradial Coronary Interventions to Prevent Spasm: A Prospective Randomized Study
Spyridon Deftereos, MD; Georgios Giannopoulos, MD; Konstantinos Raisakis, MD; et al.
J Am Coll Cardiol Intv. 2013;6(3):267-273. doi:10.1016/j.jcin.2012.11.005.
Clinical Research |  March 01, 2013
Treatment of Femoropopliteal In-Stent Restenosis With Paclitaxel-Eluting Stents
Thomas Zeller, MD; Michael D. Dake, MD; Gunnar Tepe, MD; et al.
J Am Coll Cardiol Intv. 2013;6(3):274-281. doi:10.1016/j.jcin.2012.12.118.
Left Shadow
Right Shadow
logo © 2013 American College of Cardiology Foundation
Powered bySilverchair Information Systems